The social determinants of emergency department and hospital use by injection drug users in Canada
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The aim of this study was to describe the relationship between sociodemographic characteristics and human immunodeficiency (HIV) status of a cohort of injection drug users (IDUs) on their self-reported health service utilization.
IDUs who had injected illicit drugs within the previous month were recruited through street outreach. They underwent serology for HIV-1 and questionnaires on demographics, drug using behaviors, housing status, and health service utilization (hospitalization overnight and emergency department visits) in the previous 6 months. Logistic regression analysis was used to identify independent associations with the use of health services.
Of 1,103 cohort participants, 65% were male, 63% were white, and 23% were HIV positive. Cocaine was the most frequently injected drug used. Almost half (47%) had used health services in the previous 6 months. The following variables were associated independently with health service utilization (adjusted odds ratio; 95% confidence interval): unstable housing, defined as living primarily in a hotel, boarding room, or transition house or on the street in the past 6 months (1.44; 1.11–1.86); female gender (1.45; 1.11–1.89); HIV-positive status (1.43; 1.06–1.92); injection of cocaine (1.50; 1.12–2.02); and primary care physician visit in past 6 months (1.91; 1.39–2.64).
IDUs with unstable housing were more likely to report emergency department and hospital use, which may be a reflection of their disorganized lifestyle or poorer health status. Further studies are required to assess the effect on the health status and health care use of IDUs of interventions that increase the availability of safe, affordable housing.
- Alcabes P, Friedland G. Injection drug use and human immunodeficiency virus infection.Clin Infect Dis. 1995;20:1467–1479.
- Strathdee SA, van Ameijden EJC, Mesquita F, Wodak A, Rana S, Vlahov DZ. Can HIV epidemics among injection drug users be prevented?AIDS. 1998;12(suppl A):S71-S79.
- Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study.AIDS. 1997;11:F59-F65. CrossRef
- Des Jarlais DC. Comments of Stimson's “Has the United Kingdom averted an epidemic of HIV-1 infection among drug users?”Addiction. 1996;91:1089–1090.
- Eskild A, Magnus P, Samuelsen SO, Sohlberg C, Kittelsen P. Differences in mortality rates and causes of death between HIV positive and HIV negative intravenous drug users.Int J Epidemiol. 1993;22:315–321.
- van Haastrecht JAR, van Ameijden EJC, van den Hoek JAR, Mientes GHC, Bax JS Coutinho RA. Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users.Am J Epidemiol. 1996;143: 380–391.
- Rietmejeer CA, Davidson AJ, Foster CT, Cohn DL. Cost of care for patients with human immunodeficiency virus: patterns of utilization and charges in a public health care system.Arch Intern Med. 1993;153:219–225.
- Mor V, Fleishman JA, Dresser M, Piette J. Variation in health service use among HIV-infected patients.Med Care. 1992;30:17–29.
- British Columbia Centre for Excellence in HIV/AIDS.Therapeutic Guidelines for the Treatment of HIV/AIDS and Related Conditions. Vancouver, BC: St. Paul's Hospital; 1996.
- Patrick DM, Strathdee SA, Archibald CP et al. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver.Int J STD AIDS. 1997;8:437–445. CrossRef
- Latkin C, Mandell W, Vlahov D, Oziemkowska M, Celentano D. People and places: behavioural settings and personal network characteristics as correlates of needle sharing.J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13:273–280.
- Friedman SR, Jose B, Deren S, Des Jarlais DC, Neaigus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities.Am J Epidemiol. 1995;142:864–874.
- Gostin LO, Lazzarini Z, Jones TS, Flaherty K. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users.JAMA. 1997;277:53–64.
- Hartgers C, Van Ameijden EF, van den Hoek JA, Coutinho RA. Needle sharing and participating in the Amsterdam syringe exchange programme among HIV-seronegative injecting drug users.Public Health Rep. 1992;102:675–681.
- Reyes JC, Robles RR, Colon HM, Freeman DH, Sahai H, Matos TD. Risk factors for shooting gallery use among drug injectors in Puerto Rico.P R Health Sci J. 1996;15: 227–231.
- Salit SA, Kuhn EM, Hartz AJ, Vu JM, Mosso AL. Hospitalization costs associated with homelessness in New York City.N Engl J Med. 1998;338:1734–1740. CrossRef
- Hellinger F. The use of health services by women with HIV infection.Health Serv Res. 1993;28:543–561.
- Solomon L, Frank R, Vlahov D, Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus.Am J Public Health. 1991;81: 1285–1290.
- Solomon L, Stein M, Flynn C et al. Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS).J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:253–261.
- Graham NMH, Jacobson LP, Kuo V, Chmiel JS, Morgenstern H, Zucconi S. Access to therapy in the multicenter AIDS cohort study, 1989–1992.J Clin Epidemiol. 1994;47: 1003–1012. CrossRef
- Spijkerman IJ, van Ameijden EJ, Mientjes GH, Coutinho RA, van den Hoek A. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users.J Clin Epidemiol. 1996;49:1149–1157. CrossRef
- Mientjes GH, Spijkerman IJ, van Ameijden EJ, van den Hoek A, Coutinho RA. Incidence and risk factors for pneumonia in HIV infected and non-infected drug users.J Infect. 1996;32:181–186. CrossRef
- Hudgins R, McCusker J, Stoddard A. Cocaine use and risky injection and sexual behaviours.Drug Alcohol Depend. 1995;37:7–14.
- The social determinants of emergency department and hospital use by injection drug users in Canada
Journal of Urban Health
Volume 76, Issue 4 , pp 409-418
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Drug Users
- Health Services Utilization
- Dr. Anita Palepu MD, MPH (1)
- Dr. Steffanie A. Strathdee PhD (2) (3)
- Dr. Robert S. Hogg PhD (2) (3) (4)
- Dr. Aslam H. Anis PhD (2) (3)
- Mr. Sandra Rae MSc (5)
- Ms. Peter G. A. Cornelisse MSc (3)
- Dr. David M. Patrick MD, MHSc (4) (6)
- Dr. Michael V. O'Shaughnessy PhD (3) (7)
- Dr. Martin T. Schechter MD, PhD (2) (3) (5)
- Author Affiliations
- 1. Room 620-B, Burrard Building, St. Paul's Hospital, 1081 Burrard Street, V6Z 1Y6, Vancouver, BC, Canada
- 2. Department of Health Care and Epidemiology, University of British Columbia, British Columbia, Canada
- 3. British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, British Columbia, Canada
- 4. Department of Medicine, Faculty of Medicine, University of British Columbia, British Columbia, Canada
- 5. Canadian HIV Trials Network, St. Paul's Hospital, Canada
- 6. British Columbia Centre for Disease Control, BC Ministry of Health, British Columbia, Canada
- 7. Department of Pathology, University of British Columbia, British Columbia, Canada